stoxline Quote Chart Rank Option Currency Glossary
  
(ARTL)
  0 (0%)    02-21 15:55
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2026-02-20 4:43:40 PM
Short term     
Mid term     
Targets 6-month :  1.84 1-year :  2.19
Resists First :  1.58 Second :  1.87
Pivot price 1.39
Supports First :  1.1 Second :  0.91
MAs MA(5) :  1.25 MA(20) :  1.48
MA(100) :  2.27 MA(250) :  5.62
MACD MACD :  -0.2 Signal :  -0.1
%K %D K(14,3) :  30.2 D(3) :  17.6
RSI RSI(14): 43
52-week High :  28.6 Low :  1.1
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ARTL ] has closed above bottom band by 37.9%. Bollinger Bands are 46.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.5 - 1.51 1.51 - 1.52
Low: 1.3 - 1.31 1.31 - 1.32
Close: 1.31 - 1.32 1.32 - 1.33
Company Description

Headline News

Thu, 19 Feb 2026
Gainers Report: Is ARTL still a buy after recent gains - 2025 Technical Overview & Fast Gain Stock Trading Tips - baoquankhu1.vn

Thu, 19 Feb 2026
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mon, 16 Feb 2026
Why analysts upgrade ARTL stock - Portfolio Growth Summary & Fast Entry and Exit Trade Plans - mfd.ru

Thu, 29 Jan 2026
ARTL: All proposals passed, with directors re-elected and no shareholder questions submitted - TradingView

Tue, 23 Dec 2025
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate - Yahoo Finance

Wed, 03 Dec 2025
Artelo (Nasdaq: ARTL) study: FABP5 inhibitor reduces anxiety, depression in rats - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 2 (M)
Shares Float 2 (M)
Held by Insiders 0.4 (%)
Held by Institutions 3.2 (%)
Shares Short 124 (K)
Shares Short P.Month 186 (K)
Stock Financials
EPS -19.86
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.41
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -136.3 %
Return on Equity (ttm) -436.2 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -8 (M)
Levered Free Cash Flow -3 (M)
Stock Valuations
PE Ratio -0.07
PEG Ratio 0
Price to Book value -3.22
Price to Sales 0
Price to Cash Flow -0.33
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android